GAMMA Investing LLC Invests $33,000 in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

GAMMA Investing LLC bought a new stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 2,462 shares of the real estate investment trust’s stock, valued at approximately $33,000.

Other hedge funds also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its stake in shares of Sabra Health Care REIT by 709.0% in the third quarter. JPMorgan Chase & Co. now owns 13,504,420 shares of the real estate investment trust’s stock worth $188,252,000 after buying an additional 11,835,109 shares during the last quarter. American Century Companies Inc. boosted its stake in shares of Sabra Health Care REIT by 41.8% in the third quarter. American Century Companies Inc. now owns 2,109,005 shares of the real estate investment trust’s stock worth $29,400,000 after buying an additional 622,133 shares during the last quarter. LDR Capital Management LLC purchased a new stake in shares of Sabra Health Care REIT in the third quarter worth about $7,076,000. abrdn plc boosted its stake in shares of Sabra Health Care REIT by 108.0% in the fourth quarter. abrdn plc now owns 974,350 shares of the real estate investment trust’s stock worth $13,904,000 after buying an additional 506,011 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its stake in shares of Sabra Health Care REIT by 1.5% in the third quarter. Principal Financial Group Inc. now owns 21,003,193 shares of the real estate investment trust’s stock worth $292,783,000 after buying an additional 313,517 shares during the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft began coverage on Sabra Health Care REIT in a research note on Tuesday, January 30th. They issued a “buy” rating and a $21.00 target price on the stock. Wedbush reiterated an “outperform” rating and set a $17.00 price target on shares of Sabra Health Care REIT in a research report on Thursday, February 29th. Five research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $15.77.

Sabra Health Care REIT Price Performance

Shares of Sabra Health Care REIT stock opened at $14.35 on Monday. The business has a 50 day simple moving average of $14.09 and a two-hundred day simple moving average of $14.03. Sabra Health Care REIT, Inc. has a 12 month low of $10.30 and a 12 month high of $14.91. The stock has a market capitalization of $3.32 billion, a P/E ratio of 287.00, a PEG ratio of 5.15 and a beta of 1.17. The company has a debt-to-equity ratio of 0.86, a current ratio of 3.41 and a quick ratio of 3.41.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.